India's Biocon to set up insulin plant in Malaysia

Status
Not open for further replies.

Northerner

Admin (Retired)
Relationship to Diabetes
Type 1
India's top biotechnology firm Biocon is expanding into Southeast Asia by opening a manufacturing facility in Malaysia's Johor state to produce insulin at an affordable price, chairperson Kiran Mazumdar-Shaw said.

Speaking to visiting Asean journalists, the Biocon chief said the first phase should cost US$160 million (Bt3.7 billion) and the facility should start producing by 2014. The facility, investment for which is the largest in Malaysia's biotechnology sector, will become a production base not just for Southeast Asia but also for the global market, she said.

Biocon is currently conducting clinical trials for insulin with a partner in Thailand, where the market for the product is sizeable, she said. Mazumdar-Shaw established the company in 1987 as a pioneer in biotechnology for healthcare. The company now has more than 5,500 workers.

Biocon's objective is to produce pharmaceutical products at affordable prices, she said, noting that the company had managed to bring down the price of insulin significantly.

http://www.nationmultimedia.com/bus...et-up-insulin-plant-in-Malaysia-30176212.html
 
Status
Not open for further replies.
Back
Top